Dr Isabel Jakobs has extensive experience in product regulatory advisory work and product liability law. She has a particular focus on the life sciences and healthcare industry, advising pharmaceutical and medical device companies, hospitals, biotechnology firms as well as chemical and tobacco corporations. In the area of M&A, she regularly guides clients through complex transactions with a product regulatory dimension — from regulatory due diligence and deal structuring through to post-merger integration. She also advises on a wide range of sophisticated matters, including market access strategies, digitalisation in healthcare, product regulation, product-related environmental law and social security law. Beyond these core sectors, Isabel Jakobs regularly counsels clients across numerous other industries on product compliance matters. She has authored a wealth of publications and serves on the advisory board of the specialist journal "Medizinprodukte Journal" (MPJ). She also lectures regularly on quality management at the University of Kassel and is a frequent speaker on product regulatory topics at national and international conferences.

Distinctions

  • Legal 500
    Recommended for Health, Product Liability and Litigation

Career

Studied law at Ludwig Maximilian University in Munich
Traineeship under the remit of Munich Higher Regional Court, including a seat at a leading international commercial law firm in Paris
Doctorate (Dr. jur.) at Augsburg University
Experience as a lawyer with an international law firm in Munich with a focus on life sciences
At Noerr since 2019
Admitted to the Munich Chamber of Lawyers

Lectures

  • "Quality and Law"; regular guest lecture at the University of Kassel

Publications

  • Medizinprodukterecht Nomos Kommentar
  • Germany - Liability for Medicinal Products and the Right to Disclosure under German Law" (co-author, in European Pharmaceutical Law Review 2/2018)
  • Comment on a decision of Kammergericht Berlin, ruling of 23 May 2016, 20 U 207/15 (co-author, in MPR 2/2018)
  • Betreiberspezifische Aspekte der neuen Europäischen Medizinprodukteverordnung (co-author, in GuP 2017)
  • Rückruf fehlerhafter Medizinprodukte bei deliktischer Produkthaftung, Dissertationsschrift (PhD thesis), published in „Augsburger Schriften zum Arzneimittel und Medizinprodukterecht"
  • Software als Medizinprodukt: Haftungs- und versicherungsrechtliche Aspekte (co-author, in MPR 1/2019)
  • Messverfahren von Emissionshöchstwerten bei Zigaretten und Zulässigkeit des Verweises auf (private) ISO-Normen“ (comment on ECJ ruling, February 22, 2022 - C-160/20; in ZfPC 3/2022).
  • Doctor A.I.: Künstliche Intelligenz und Medizinprodukte, (in Robotik und Produktion, 21 April 2022)
  • Poland: Advertising Medical Devices – The New European and Polish Regulatory Framework (co-author, in CEE Legal Matters, 7 February 2023)

Well
informed

Subscribe to our newsletter now to stay up to date on the latest developments.

Subscribe now